Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
about
Management of thalidomide toxicity.Endocrine side effects of broad-acting kinase inhibitors.Thyroid dysfunction from antineoplastic agents.The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidism.Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma.Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism.Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: results of a retrospective case review.Novel immunomodulatory compounds in multiple myeloma.Thalidomide-induced sinus bradycardia.Thalidomide in 42 patients with prurigo nodularis Hyde.Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.Lenalidomide-associated hypothyroidism.Pomalidomide-induced hypothyroidism.Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma.Severe hypothyroidism after thalidomide treatment.
P2860
Q34343991-3338B16B-60BC-4E8A-BFCB-0487AD9EBB1AQ34574985-25D7B404-522C-46B3-A212-4911ABC470D3Q35500038-BCAAE783-06BF-4578-819F-8F29AD9E201EQ36612613-03FE017C-680C-43F5-AED3-385E6B741879Q37212903-D95C1844-92B9-48A4-B03B-61988B252B46Q37842346-3AE7E396-8B4C-4C7D-B069-1D5D7953B6B3Q37843790-75467F48-1407-4700-BE25-FC91EAD605B1Q37872263-D75D4D5B-889C-429F-96A8-6B5A9EC1D63DQ38069614-92390651-3005-42E9-8AFE-688A5CAE16BEQ42166156-CF21C23D-EF17-482D-A5BA-6432DDE04BB3Q44029550-9D263F97-E77B-4448-93C2-189AF2904B8AQ45252391-4FA07096-DCEA-41CD-B3A7-24D351E7A11DQ46860341-CB45005C-D49D-4EA2-8A85-61C5B09847AAQ47157931-F734E9FC-B8ED-47C4-8915-56ACEEFB05D0Q53287584-4ACE71B0-6A4B-43D1-A5BA-8180E804447DQ55128803-9A20928D-C141-4311-B187-800B7108D0D9
P2860
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
@en
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
@nl
type
label
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
@en
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
@nl
prefLabel
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
@en
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
@nl
P2093
P1476
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide.
@en
P2093
Ashraf Z Badros
Donald Bodenner
Eric Siegel
Guido Tricot
Jerome Zeldis
P304
P356
10.1016/S0002-9343(01)01137-8
P407
P577
2002-04-01T00:00:00Z